drugset / Trial / NCT00206505

Neoadjuvant Taxotere

NCT00206505 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purposes of this study are to better understand how Taxotere causes tumors to become smaller and to find out how effective Taxotere is in treating the type of breast cancer that you have.

Timeline

Start
1999-01
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — —

Indications